Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.

Lu TX, Wu S, Cai DY, Hong TT, Zhang Y, Gao HQ, Hua HY, Wu XH.

BMC Cancer. 2019 Jun 8;19(1):553. doi: 10.1186/s12885-019-5758-2.

2.

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.

Xu-Monette ZY, Li L, Byrd JC, Jabbar KJ, Manyam GC, Maria de Winde C, van den Brand M, Tzankov A, Visco C, Wang J, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Winter JN, Wang M, Hagemeister FB, Piris MA, Han van Krieken J, Medeiros LJ, Li Y, van Spriel AB, Young KH.

Blood. 2016 Dec 29;128(26):3083-3100. doi: 10.1182/blood-2016-05-715094. Epub 2016 Oct 19.

3.

Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.

Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N.

J Egypt Natl Canc Inst. 2011 Mar;23(1):17-24. doi: 10.1016/j.jnci.2011.07.003. Epub 2011 Sep 8.

4.

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.

Wu S, Zhou Y, Hua HY, Zhang Y, Zhu WY, Wang ZQ, Li J, Gao HQ, Wu XH, Lu TX, Hua D.

BMC Cancer. 2018 Oct 19;18(1):997. doi: 10.1186/s12885-018-4914-4.

5.

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.

Xie W, Zhou D, Hu K, Xiao X, Huang W, He J, Shi J, Luo Y, Zhang J, Lin M, Cai Z, Huang H, Ye X.

Exp Ther Med. 2013 Jul;6(1):109-114. Epub 2013 Apr 25.

6.

[The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].

Song JL, Wei XL, Zhang YK, Hao XX, Huang WM, Wei Q, Wei YQ, Feng R.

Zhonghua Xue Ye Xue Za Zhi. 2018 Sep 14;39(9):739-744. doi: 10.3760/cma.j.issn.0253-2727.2018.09.007. Chinese.

PMID:
30369184
7.

Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.

Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST.

Ann Hematol. 2009 May;88(5):417-24. doi: 10.1007/s00277-008-0604-7. Epub 2008 Sep 7.

PMID:
18777110
8.

[Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].

Yang YL, Wang J, Zhao LZ, Gao ZF, Jing HM, Ke XY.

Ai Zheng. 2008 Jun;27(6):636-41. Chinese.

PMID:
18570740
9.

The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

Troppan KT, Melchardt T, Deutsch A, Schlick K, Stojakovic T, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Egle A, Pichler M.

Eur J Haematol. 2015 Dec;95(6):538-44. doi: 10.1111/ejh.12529. Epub 2015 Mar 26.

PMID:
25677782
10.

[A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].

He Y, Wang L, Zhu HY, Liang JH, Wu W, Wu JZ, Xia Y, Cao L, Fan L, Li JY, Xu W.

Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):505-510. doi: 10.3760/cma.j.issn.0253-2727.2017.06.008. Chinese.

PMID:
28655094
11.

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.

Bairey O, Shacham-Abulafia A, Shpilberg O, Gurion R.

Hematol Oncol. 2016 Dec;34(4):184-192. doi: 10.1002/hon.2233. Epub 2015 Jun 5.

PMID:
26052918
12.

Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.

Wang Y, Li YJ, Jiang WQ, Rao HL, Huang JJ, Xia Y, Bi X, Sun P, Huang HQ, Lin TY, Guan ZZ, Li ZM.

Ann Hematol. 2015 Nov;94(11):1865-73. doi: 10.1007/s00277-015-2490-0. Epub 2015 Sep 2.

PMID:
26327569
13.

Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma.

Wei X, Huang F, Wei Y, Jing H, Xie M, Hao X, Feng R.

Leuk Res. 2014 Jun;38(6):694-8. doi: 10.1016/j.leukres.2014.03.013. Epub 2014 Mar 25.

PMID:
24713260
14.

The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma.

Yue W, Liu B, Gao L, He M, Wang J, Zhang W, Chen L, Hu X, Xu L, Yang J.

Clin Chim Acta. 2018 Oct;485:316-322. doi: 10.1016/j.cca.2018.07.015. Epub 2018 Jul 11.

PMID:
30006285
15.

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.

Terol MJ, Tormo M, Martinez-Climent JA, Marugan I, Benet I, Ferrandez A, Teruel A, Ferrer R, García-Conde J.

Ann Oncol. 2003 Mar;14(3):467-74.

PMID:
12598355
16.

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G; German High-Grade Lymphoma Study Group.

J Clin Oncol. 2017 Aug 1;35(22):2515-2526. doi: 10.1200/JCO.2016.70.3660. Epub 2017 May 19.

PMID:
28525305
17.

Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Cho MC, Chung Y, Jang S, Park CJ, Chi HS, Huh J, Suh C, Shim H.

Medicine (Baltimore). 2018 Nov;97(45):e13046. doi: 10.1097/MD.0000000000013046.

18.

[Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma].

Zhao SX, Han Y, Zhu Q, Wang Q, Zhang WJ, Chen XC, Sun AN, Jin ZM, Qiu HY, Tang XW, Fu ZZ, He GS, Miao M, Ma X, Wu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):623-7. doi: 10.7534/j.issn.1009-2137.2013.03.017. Chinese.

PMID:
23815910
19.

Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.

Han Y, Yang J, Liu P, He X, Zhang C, Zhou S, Zhou L, Qin Y, Song Y, Sun Y, Shi Y.

Oncologist. 2019 Apr 5. pii: theoncologist.2018-0361. doi: 10.1634/theoncologist.2018-0361. [Epub ahead of print]

PMID:
30952824
20.

Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases.

Zhou D, Xie WZ, Hu KY, Huang WJ, Wei GQ, He JS, Shi JM, Luo Y, Li L, Zhu JJ, Zhang J, Lin MF, Ye XJ, Cai Z, Huang H.

Asian Pac J Cancer Prev. 2013;14(2):929-34.

Supplemental Content

Support Center